Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3

3(42.9%)

Early Phase 1

2(28.6%)

Phase 2

1(14.3%)

Phase 1

1(14.3%)

7Total

Phase 3(3)

Early Phase 1(2)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06648850Phase 2Not Yet Recruiting

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

Role: collaborator

NCT07397325Phase 1Not Yet Recruiting

Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

Role: collaborator

NCT07402330Early Phase 1Not Yet Recruiting

Pharmacokinetic Study of DA-020

Role: collaborator

NCT07033845Early Phase 1Recruiting

Pharmacokinetic Study of Topical Phenylephrine

Role: collaborator

NCT06762548Phase 3Not Yet Recruiting

Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia

Role: collaborator

NCT06501924Phase 3Not Yet Recruiting

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

Role: collaborator

NCT06484881Phase 3Withdrawn

Clinical Study of Probiotic Treatment for Androgenetic Alopecia

Role: collaborator

All 7 trials loaded